A kind of paracetamol being marketed under the brand name Paraveganio is now available in Germany. What makes this medicine special is the fact that it is made with plant-based ingredients only, and it is the first of its kind in the world.
PlantBased News reported that the new medicinal drug is now vegan-certified and the world’s first to be registered with The Vegan Trademark, a trusted vegan labeling being managed by The Vegan Society, a recognized charity and the oldest vegan organization in the world.
Paraveganio was developed by a German pharma firm called Axunio. It was made using 100% plant-based ingredients, and it is now the first product to be certified as vegan by The Vegan Society. Paracetamol is used worldwide as a painkiller and can be purchased over-the-counter, but this medicine contains an animal-derived additive called the magnesium stearate.
Most pharma companies use this additive for lubricating properties in tablets and capsules. The stearic acid that it contains is an ingredient that is made with animal fats.
The plant-based Paraveganio paracetamol is free from magnesium stearate sourced from animals. Rather, this was taken from pure vegetable sources. Axunio guaranteed that its 500 mg. paracetamol tablets are 100% vegan drug that can be taken to relieve mild and moderate pain as well as reduce fever.
“We could not be prouder to be bringing the world’s first vegan-certified drug to the market. Of course, to have it certified by The Vegan Society’s Vegan Trademark – the gold standard in vegan labeling - makes it that much more special too,” Axunio’s product and business development manager, Julia von Horsten, said in a press release.
She added, “Many people are surprised to hear that the majority of medications, including over-the-counter products such as paracetamol, contain animal derivatives or have been tested on animals. We know there’s a gap in the market for vegan certified paracetamol and are so delighted to be able to offer our product to consumers.”
Meanwhile, this is a good innovation, but the Paraveganio tablets are only available in Germany at the moment. Then again, this may soon reach other countries as Axunio is planning to bring its vegan paracetamol to other markets too.


BHP Port Hedland Workers Back Strike Action Amid Pay Dispute
Frasers Group Launches €2 Billion Hugo Boss Takeover Offer Amid Control Speculation
Asian Stocks Rally as Trump Signals Iran Peace Deal; Tech and Chip Shares Rebound Strongly
Meta Partners With Reliance to Launch First AI-Powered Data Center in India
European Stocks Rise Ahead of ECB Rate Decision as Investors Buy the Dip
Asian Stocks Surge as Middle East Peace Hopes Lift Markets; SpaceX IPO Shatters Records
Oracle Stock Falls Despite Earnings Beat as Company Plans $40 Billion Financing for FY2027
ECB Keeps July Rate Options Open Amid Iran War Energy Price Risks
Changchun Targets EV Growth as China’s Auto Industry Consolidation Accelerates
Astera Labs and Rocket Lab Surge After Nasdaq-100 Inclusion Announcement
Oil Prices Fall as Trump Signals Iran Deal, Reducing Supply Risk Concerns
South Korea Signals Possible Interest Rate Hike as Inflation Remains Elevated
Trump Administration Defends Anthropic AI Restrictions in Ongoing Federal Lawsuit
New Zealand Manufacturing Slips Back Into Contraction in May
Russia Stocks End at Six-Month Low as MOEX Index Stalls, Gold Surges and Oil Retreats
Adobe Beats Q2 2026 Estimates, Raises Full-Year Outlook as AI Revenue Surges Despite Stock Drop
Carney and Macron Strengthen Canada-France Defense Ties Amid US Trade Uncertainty 



